Spruce Biosciences, Inc.
SPRBNasdaqCIK 1683553HealthcareFiscal year ends Dec 31
Reports and events: 115 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1209:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-345876 |
| 2026-08-1209:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-345874 |
| 2026-07-2708:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-316928 |
| 2026-05-2616:02 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-239230 |
| 2026-05-1316:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-221605 |
| 2026-05-1308:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-220648 |
| 2026-04-2217:50 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-167332 |
| 2026-04-0917:02 ET | DEF 14A | Proxy statementPeriod 2026-04-09 | 0001193125-26-149821 |
| 2026-03-2017:04 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-26-117888 |
| 2026-03-0907:23 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-097561 |
| 2026-03-0907:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-097558 |
| 2026-02-1822:27 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-007364 |
| 2026-02-0516:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-039399 |
| 2026-01-0808:05 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-007038 |
| 2025-12-1508:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-318488 |
| 2025-12-1216:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-317532 |
| 2025-11-1016:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274234 |
| 2025-11-1016:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274216 |
| 2025-10-1716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-242488 |
| 2025-10-0917:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001012975-25-000624 |
| 2025-10-0816:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-234516 |
| 2025-08-1416:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108888 |
| 2025-08-1416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108868 |
| 2025-07-2416:12 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-098340 |
| 2025-06-1208:10 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-085144 |
| 2025-05-2907:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-078590 |
| 2025-05-0616:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064463 |
| 2025-05-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064429 |
| 2025-04-2816:05 ET | DEF 14A | Proxy statementPeriod 2025-06-09 | 0000950170-25-059288 |
| 2025-04-2517:15 ET | 8-K | 2.05 Exit or disposal costs; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-058863 |
| 2025-04-1507:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-053945 |
| 2025-04-1507:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-053944 |
| 2025-04-0117:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-048726 |
| 2025-01-1011:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-002369 |
| 2024-12-2717:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-140833 |
| 2024-12-1016:08 ET | 8-K | 8.01 Other events | 0000950170-24-134969 |
| 2024-11-1206:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124479 |
| 2024-11-1206:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124436 |
| 2024-10-2817:15 ET | 8-K | 3.01 Delisting notice | 0000950170-24-117786 |
| 2024-08-1216:18 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095461 |
| 2024-08-1216:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095417 |
| 2024-06-1817:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-074990 |
| 2024-06-0307:05 ET | 8-K | 8.01 Other events | 0000950170-24-067650 |
| 2024-05-2416:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-064561 |
| 2024-05-1316:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058657 |
| 2024-05-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058635 |
| 2024-04-3017:00 ET | 8-K | 3.01 Delisting notice | 0000950170-24-050612 |
| 2024-04-0516:12 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0000950170-24-042270 |
| 2024-03-2821:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-081224 |
| 2024-03-2521:48 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-076792 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.